Andrew Didham
Non-Executive Director
immunology
JLT Essential EAP
Italy
Biography
Andrew Didham was appointed a Non-executive Director on 2 October 2017 and was appointed as Chairman of the Audit & Risk Committee on 3 October 2017. Andrew is also a member of the Remuneration and Nominations Committees. Andrew has been a Non-executive Director and Chairman of the Audit Committee at Shawbrook Group plc since February 2017. He has been a Non-executive Director of Charles Stanley Group plc since September 2015, where he is also Senior Independent Director, Chairman of the Risk Committee and a member of the Nominations, Audit and Remuneration Committees.
Research Interest
Andrew was previously Group Finance Director of Rothschild, the international investment banking group, from 1997 to 2012. He became an Executive Vice Chairman of Rothschild in 2012 and remains a director of NM Rothschild & Sons, the UK business of the Rothschild group. Andrew is a Chartered Accountant and before joining Rothschild he spent 20 years at KPMG/Thomson McLintock, including as a Partner. His experience includes audit responsibility for a number of global financial institutions, assignments on behalf of the Bank of England and the EU, and extensive dealings with regulatory authorities in the UK, Europe, Asia, Australia and the USA.
